CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights Switching P2Y12-receptor inhibitors in patients with coronary artery disease Percutaneous Support Devices for Percutaneous Coronary Intervention Canadian Multicenter Chronic Total Occlusion Registry: Ten-Year Follow-Up Results of Chronic Total Occlusion Revascularization Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4

Original Research13 Sep 2021

JOURNAL:Circ Res. Article Link

Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4

MM Liu, M Yan, D Ai et al. Keywords: post infarction; myocardial infarction; inhibition of inflammation; macrophage

Full Text PDF